BRIEF-Dioseve Secures JPY 1.45 Billion To Advance iPS Cell‑Based IVF Support

June 16 (Reuters) - Dioseve Inc:

  • DIOSEVE SECURES JPY 1.45 BILLION TO ADVANCE IPS CELL‑BASED IVF SUPPORT, ADDS TIME100 SCIENTIST AS ADVISOR

  • DIOSEVE INC - FINANCING BRINGS CO'S CUMULATIVE EQUITY FUNDING TO JPY 2.5 BILLION

  • DIOSEVE INC - ARCHETYPE VENTURES SERVED AS LEAD INVESTOR, WITH PARTICIPATION FROM DG DAIWA VENTURES AND MIRAI DOOR

  • DIOSEVE INC - NEW INVESTORS D4V, SHIONOGI CO., LTD., AND PANGAEA VENTURES ALSO JOINED ROUND

Source text: ID:nPn6Qf9nda


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.